{
  "abstract": "There is no question that the assessment of long-term outcomes is a core component of neonatal care and research. The effects of medicinal products or other interventions administered to newborns may be detected well beyond the neonatal period, even where childhood impacts may not be anticipated as a direct consequence of the intervention. Neurodevelopmental assessments are increasingly used in the evaluation of the efficacy and safety of neonatal interventions. Developmental outcomes are also of paramount importance to parents, carers and graduates of neonatal care, reflected in their prominence in core outcome sets and priority setting partnerships in neonatology.",
  "authors": [
    {
      "affiliations": [
        "School of Healthcare, University of Leicester, Leicester, UK"
      ],
      "name": "Samantha Johnson"
    },
    {
      "affiliations": [
        "Institute for Women's Health, University College London, London, UK"
      ],
      "name": "Neil Marlow"
    }
  ],
  "title": "Parent reports as developmental outcome measures in neonatal trials: the way forward?",
  "uid": "b7f23a0b-d15d-5d6a-89f2-b5ec60f6749f"
}